Sourabh Shukla
Overview
Explore the profile of Sourabh Shukla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Z, Xiang Y, Koellhoffer E, Shukla S, Fiering S, Chen S, et al.
Mater Adv
. 2024 Feb;
5(4):1480-1486.
PMID: 38380337
Implantable polymeric hydrogels loaded with immunostimulatory cowpea mosaic virus (CPMV) were fabricated using digital light processing (DLP) printing technology. The CPMV-laden hydrogels were surgically implanted into the peritoneal cavity to...
2.
de Oliveira J, Zhao Z, Xiang Y, Shin M, Villasenor K, Deng X, et al.
Front Microbiol
. 2023 May;
14:1117494.
PMID: 37152732
The COVID-19 pandemic caused by SARS-CoV-2 sparked intensive research into the development of effective vaccines, 50 of which have been approved thus far, including the novel mRNA-based vaccines developed by...
3.
Ghani M, Bangar A, Yang Y, Jung E, Sauceda C, Mandt T, et al.
J Vasc Interv Radiol
. 2023 Mar;
34(7):1247-1257.e8.
PMID: 36997021
Purpose: To test the hypothesis that cryoablation combined with intratumoral immunomodulating nanoparticles from cowpea mosaic virus (CPMV) as an in situ vaccination approach induces systemic antitumoral immunity in a murine...
4.
Chung Y, Church D, Koellhoffer E, Osota E, Shukla S, Rybicki E, et al.
Nat Rev Mater
. 2021 Dec;
7(5):372-388.
PMID: 34900343
Biologics - medications derived from a biological source - are increasingly used as pharmaceuticals, for example, as vaccines. Biologics are usually produced in bacterial, mammalian or insect cells. Alternatively, plant...
5.
Ortega-Rivera O, Shukla S, Shin M, Chen A, Beiss V, Moreno-Gonzalez M, et al.
ACS Infect Dis
. 2021 Oct;
7(11):3096-3110.
PMID: 34672530
The development of vaccines against coronaviruses has focused on the spike (S) protein, which is required for the recognition of host-cell receptors and thus elicits neutralizing antibodies. Targeting conserved epitopes...
6.
Nkanga C, Chung Y, Shukla S, Zhou J, Jokerst J, Steinmetz N
Biomater Sci
. 2021 Sep;
9(21):7134-7150.
PMID: 34591046
Plant virus nanoparticles (VNPs) have multiple advantages over their synthetic counterparts including the cost-effective large-scale manufacturing of uniform particles that are easy to functionalize. Tobacco mosaic virus (TMV) is one...
7.
Patel B, Wang C, Lorens B, Levine A, Steinmetz N, Shukla S
ACS Appl Bio Mater
. 2021 Aug;
3(7):4179-4187.
PMID: 34368641
Cancer vaccines are promising adjuvant immunotherapies that can stimulate the immune system to recognize tumor-associated antigens and eliminate the residual or recurring disease. The aberrant and restricted expression of highly...
8.
Cai H, Shukla S, Steinmetz N
Adv Funct Mater
. 2021 Aug;
30(15).
PMID: 34366757
Oligodeoxynucleotides (ODNs) with CpG motifs have potent immunostimulatory effects on many subsets of immune cells. For example, Class B CpG-ODNs, such as ODN1826 induce the phagocytic activity of macrophages by...
9.
Shukla S, Marks I, Church D, Chan S, Pokorski J, Steinmetz N
RSC Adv
. 2021 Jun;
11(33):20101-20108.
PMID: 34178308
Prostate-specific membrane antigen (PSMA) is a membrane-bound protein that is preferentially expressed in the prostate gland and induced in many prostate cancers, making it an important target for new diagnostics...
10.
Boone C, Wang C, Lopez-Ramirez M, Beiss V, Shukla S, Chariou P, et al.
ACS Appl Nano Mater
. 2021 May;
3(8):8037-8051.
PMID: 33969278
The solid tumor microenvironment (TME) poses a significant structural and biochemical barrier to immunotherapeutic agents. To address the limitations of tumor penetration and distribution, and to enhance antitumor efficacy of...